
Abeona Therapeutics Inc
NASDAQ:ABEO

Intrinsic Value
The intrinsic value of one
ABEO
stock under the Base Case scenario is
12.23
USD.
Compared to the current market price of 4.92 USD,
Abeona Therapeutics Inc
is
Undervalued by 60%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Abeona Therapeutics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Abeona Therapeutics Inc
Balance Sheet Decomposition
Abeona Therapeutics Inc
Current Assets | 100.9m |
Cash & Short-Term Investments | 97.7m |
Receivables | 1.7m |
Other Current Assets | 1.5m |
Non-Current Assets | 8.1m |
PP&E | 8m |
Other Non-Current Assets | 96k |
Free Cash Flow Analysis
Abeona Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Abeona Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-64.2m
USD
|
Operating Income
|
-64.2m
USD
|
Other Expenses
|
477k
USD
|
Net Income
|
-63.7m
USD
|
ABEO Profitability Score
Profitability Due Diligence
Abeona Therapeutics Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

Score
Abeona Therapeutics Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.
ABEO Solvency Score
Solvency Due Diligence
Abeona Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Score
Abeona Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ABEO Price Targets Summary
Abeona Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
ABEO
is 17.09 USD
with a low forecast of 9.6 USD and a high forecast of 26.25 USD.
Dividends
Current shareholder yield for ABEO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ABEO
stock under the Base Case scenario is
12.23
USD.
Compared to the current market price of 4.92 USD,
Abeona Therapeutics Inc
is
Undervalued by 60%.